EUVIMEDEUVIMED entdecken
Crossref

Neoadjuvant Immunochemotherapy Reduces Major Wound Complications in Oral Cancer Surgery

Jingjing Wang, Rui Zhao iD, Xu Zhang, Junhui Yuan, Qigen Fang

Head & Neck · 2026-12 · 48 (12) · 3435-3446

DOI: 10.1002/hed.70375 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, online erschienen am 01.07.2026. Verfasst von Jingjing Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Head Neck, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Mouth Neoplasms, Carcinoma, Squamous Cell, Postoperative Complications. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neoadjuvant immunochemotherapy (NICT) is emerging for locally advanced oral squamous cell carcinoma (OSCC), but its impact on postoperative wound healing remains undefined. We compared major wound complication rates between patients receiving NICT and those undergoing upfront surgery (US).

Methods

In this retrospective cohort study, 466 patients with resectable OSCC (NICT = 278, US = 188) were included. Propensity score matching (1:1) was performed using covariates influencing treatment selection and wound healing, yielding 145 balanced pairs. The primary outcome was the incidence of major wound complications (Clavien‐Dindo ≥ III) within 90 postoperative days. Secondary outcomes included time‐to‐complete wound healing, length of stay, and delay to adjuvant therapy. Multivariable regression and Cox models were used for adjustment.

Results

After matching, baseline and surgical characteristics were well‐balanced (all SMD < 0.1). The incidence of major wound complications was significantly lower in the NICT group (15.2% vs. 24.8%; p = 0.041). In multivariable analysis, upfront surgery remained an independent predictor of complications (OR = 2.15, 95% CI: 1.16–4.02, p = 0.016). Time‐to‐complete healing was shorter in the NICT group (HR = 0.66, 95% CI: 0.47–0.92, p = 0.014). Patients receiving NICT also had a shorter median hospital stay (10 vs. 12 days, p = 0.008) and lower rates of adjuvant therapy delay (18.6% vs. 31.0%, p = 0.015). Pathological response to NICT and immune‐related adverse events were not associated with wound outcomes.

Conclusion

In this matched analysis, NICT was associated with a significantly lower risk of major wound complications and faster healing compared to upfront surgery, supporting its perioperative safety and potential to improve surgical outcomes in locally advanced OSCC. Future prospective validation is required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoadjuvant TherapyMouth NeoplasmsCarcinoma, Squamous CellPostoperative ComplicationsImmunotherapyHumansFemaleRetrospective StudiesMaleMiddle AgedPropensity ScoreWound HealingAgedTreatment OutcomeLength of Stay

Stichwörter der Autor:innen

neoadjuvant immunochemotherapyoral squamous cell carcinomapropensity score matchingsurgical outcomeswound healing complications

Autor:innen und Institutionen

  • Department of Head Neck, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.
  • Department of Radiology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China.

ORCID-Profile: Rui Zhao

Zitieren

APA

Wang, J., Zhao, R., Zhang, X., Yuan, J., & Fang, Q. (2026). Neoadjuvant Immunochemotherapy Reduces Major Wound Complications in Oral Cancer Surgery. Head & Neck, 48(12), 3435-3446. https://doi.org/10.1002/hed.70375

Vancouver

Wang J, Zhao R, Zhang X, Yuan J, Fang Q. Neoadjuvant Immunochemotherapy Reduces Major Wound Complications in Oral Cancer Surgery. Head & Neck. 2026;48(12):3435-3446. doi:10.1002/hed.70375

BibTeX
@article{Wang2026,
  author = {Wang, Jingjing and Zhao, Rui and Zhang, Xu and Yuan, Junhui and Fang, Qigen},
  title = {Neoadjuvant Immunochemotherapy Reduces Major Wound Complications in Oral Cancer Surgery},
  journal = {Head & Neck},
  year = {2026},
  volume = {48},
  number = {12},
  pages = {3435--3446},
  doi = {10.1002/hed.70375}
}
Kostenlos starten →